Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−68.60 MUSD
59.39 M
About RayzeBio, Inc.
Rayzebio, Inc. provides radiopharmaceutical medicines for cancer. It develops a pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225. The company was founded by Deborah Charych, Aaron Kantoff and Aron Royston in January 2020 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RYZB is 62.4900 USD — it has increased by 0.02% in the past 24 hours. Watch RayzeBio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange RayzeBio, Inc. stocks are traded under the ticker RYZB.
RYZB reached its all-time high on Feb 22, 2024 with the price of 62.5100 USD, and its all-time low was 17.9500 USD and was reached on Sep 26, 2023. View more price dynamics on RYZB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RYZB stock is 0.03% volatile and has beta coefficient of 2.54. Track RayzeBio, Inc. stock price on the chart and check out the list of the most volatile stocks — is RayzeBio, Inc. there?
Yes, you can track RayzeBio, Inc. financials in yearly and quarterly reports right on TradingView.
RayzeBio, Inc. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
RYZB earnings for the last quarter are −1.08 USD per share, whereas the estimation was −1.08 USD resulting in a 0% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about RayzeBio, Inc. earnings.
RayzeBio, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 0 USD.
RYZB net income for the last quarter is −18.19 M USD, while the quarter before that showed −14.70 M USD of net income which accounts for −23.73% change. Track more RayzeBio, Inc. financial stats to get the full picture.
No, RYZB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RYZB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RayzeBio, Inc. stock right from TradingView charts — choose your broker and connect to your account.